Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other Accumulated Expenses (2017 - 2024)

Solid Biosciences' Other Accumulated Expenses history spans 7 years, with the latest figure at $92000.0 for Q1 2024.

  • For Q1 2024, Other Accumulated Expenses rose 67.27% year-over-year to $92000.0; the TTM value through Mar 2024 reached $92000.0, up 67.27%, while the annual FY2023 figure was $24000.0, 71.43% up from the prior year.
  • Other Accumulated Expenses for Q1 2024 was $92000.0 at Solid Biosciences, up from $24000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $162000.0 in Q3 2023 and bottomed at $14000.0 in Q4 2022.
  • The 4-year median for Other Accumulated Expenses is $67000.0 (2021), against an average of $74250.0.
  • The largest YoY upside for Other Accumulated Expenses was 408.7% in 2023 against a maximum downside of 63.33% in 2023.
  • A 4-year view of Other Accumulated Expenses shows it stood at $35000.0 in 2021, then plummeted by 60.0% to $14000.0 in 2022, then surged by 71.43% to $24000.0 in 2023, then surged by 283.33% to $92000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Other Accumulated Expenses are $92000.0 (Q1 2024), $24000.0 (Q4 2023), and $162000.0 (Q3 2023).